Clinical Education InitiativeMenu
Search
Home > Courses > Using Supervised Injection Facilities to Reduce Harm and Improve Access to Care

Using Supervised Injection Facilities to Reduce Harm and Improve Access to Care

Using Supervised Injection Facilities to Reduce Harm and Improve Access to Care
Play
Sorry, this learning module is not available for mobile devices.
Original Presentation: 2/7/2017
Web Posting: 4/17/2017
CE Expiration: 02/06/2020
Presenter
  • Sharon Stancliff, MD
    Medical Director
    Harm Reduction Coalition
Learning Objectives
At the completion of this educational session, participants will:
  1. Understand the evidence for the effectiveness of Supervised Injection Facilities (SIFs) in reducing overdose, HIV and HCV transmission, and other harms of injection drug use.
  2. Appreciate how existing SIFs fit into a continuum of care.
  3. Know several models of SIFs.
  4. Be aware of legal barriers to these facilities in the United States.
Presenter Bio
Sharon Stancliff, MD
Sharon Stancliff is the Medical Director of the Harm Reduction Coalition where she oversees SKOOP, an overdose prevention project, and runs a buprenorphine demonstration project. She is also a medical consultant for the AIDS Institute, New York State Department of Health. She has worked with drug users in methadone maintenance, primary care and at syringe exchanges and has published articles related to harm reduction and drug treatment.
Continuing Education Credit

This CME activity was approved for AMA PRA Category 1 Credit™ on February 7, 2017 and will terminate February 6, 2020.
The target audience is all physicians, NPs and PAs involved or interested in HIV education.

This online video and post-activity evaluation are one hour in length.

  • After you complete the video portion of this educational activity there will be a post-activity evaluation and quiz.
  • You must achieve at least 70% correct to receive your CME certificate.
  • If successful, you will be provided instructions to print your CME certificate at the completion of this activity.

Accreditation Statement

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the Medical Society of the State of New York (MSSNY) and the Physicians’ Research Network (PRN). MSSNY is accredited by the ACCME to provide continuing medical education for physicians.

The Medical Society of the State of New York designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit. Physicians should claim only the credit commensurate with extent of their participation in the activity.

Disclosure Statement 

Policies and standards of MSSNY require that speakers and planners for CME activities disclose any relevant financial relationships they may have with commercial interests whose products, devices or services may be discussed in the content of a CME activity.  

  • Dr. James Braun (Planner/Course Director) had no relevant financial relationships to disclose.
  • Dr. Sharon Stancliff (Presenter) has no relevant financial relationships to disclose. Dr. Stancliff submitted her slides in advance for adequate peer review, and will support her presentation and clinical recommendations with the best available evidence from the medical literature.

Financial Support

This meeting of the Physicians' Research Network (PRN) and enduring material were funded in part by educational grants from: Bristol-Myers Squibb, Gilead Sciences, Janssen Pharmaceuticals, Merck & Co, and ViiV Healthcare.

Details:

This online video and post-activity evaluation are one hour in length. 

  • After you complete the video portion of this educational activity there will be a post-activity evaluation and quiz. 
  • You must achieve at least 70% correct to receive your CME certificate. 
  • If successful, you will be provided instructions to print your CME certificate at the completion of this activity.
PRN Learning Modules